Increased SPP1 expression in TAMs can cause T cell inhibition and inhibit CD8 + T cell production of interferon-γ (IFN-γ) while also upregulating PD-L1 expression in cancer cells via the NF-κB pathway. This evidence concerns the gene NFKB1 and cancer.